This article needs more reliable medical references for verification or relies too heavily on primary sources. (May 2017)
Prognosis (Greek: πρόγνωσις "fore-knowing, foreseeing") is a medical term for predicting the likely or expected development of a disease, including whether the signs and symptoms will improve or worsen (and how quickly) or remain stable over time; expectations of quality of life, such as the ability to carry out daily activities; the potential for complications and associated health issues; and the likelihood of survival (including life expectancy). A prognosis is made on the basis of the normal course of the diagnosed disease, the individual's physical and mental condition, the available treatments, and additional factors. A complete prognosis includes the expected duration, function, and description of the course of the disease, such as progressive decline, intermittent crisis, or sudden, unpredictable crisis.
When applied to large statistical populations, prognostic estimates can be very accurate: for example the statement "45% of patients with severe septic shock will die within 28 days" can be made with some confidence, because previous research found that this proportion of patients died. This statistical information does not apply to the prognosis for each individual patient, because patient-specific factors can substantially change the expected course of the disease: additional information is needed to determine whether a patient belongs to the 45% who will die, or to the 55% who survive.
Disease and prognostic indicators
Prognostic scoring is also used for cancer outcome predictions. A Manchester score is an indicator of prognosis for small-cell lung cancer. For Non-Hodgkin lymphoma, physicians have developed the International Prognostic Index to predict patient outcome.
Other medical areas where prognostic indicators are used is in Drug-Induced Liver Injury (DILI) (Hy's law) and use of an exercise stress test as a prognostic indicator after myocardial infarction, also used to indicate multiple myeloma survival rate.
End of life
Studies have found that most doctors are overly optimistic when making a prognosis; they tend to overstate how long a patient might live. For patients who are critically ill, particularly those in an intensive care unit, there are numerical prognostic scoring systems that are more accurate. The most famous of these is the APACHE II scale, which is most accurate when applied in the seven days prior to a patient's predicted death.
Knowing the prognosis helps determine whether it makes more sense to attempt certain treatments or to withhold them, and thus plays an important role in end-of-life decisions and advanced care planning.
Estimators that are commonly used to describe prognoses include:
- Progression-free survival - the length of time during and after medication or treatment during which the disease being treated (usually cancer) does not get worse.
- Survival rate - indicating the percentage of people in a study or treatment group who are alive for a given period of time after diagnosis.
- Survival time - the remaining duration of life. If not otherwise specified, it generally starts from the time of diagnosis.
One of the earliest written works of medicine is the Book of Prognostics of Hippocrates, written around 400 BC. This work opens with the following statement: "It appears to me a most excellent thing for the physician to cultivate Prognosis; for by foreseeing and foretelling, in the presence of the sick, the present, the past, and the future, and explaining the omissions which patients have been guilty of, he will be the more readily believed to be acquainted with the circumstances of the sick; so that men will have confidence to intrust themselves to such a physician."
For 19th century physicians, particularly those following the French school of medicine, the main aim of medicine was not to cure disease, but rather to give a medical diagnosis and achieve a satisfying prognosis of the patient's chances. Only several decades later did the focus of efforts in Western medicine shift to curing disease.
- ^ "What is the prognosis of a genetic condition?". Genetics Home Reference. NIH: U.S. National Library of Medicine. Retrieved 2018-05-20.
- ^ a b "Prognosis". Nature Publishing Group. Retrieved 20 May 2018.
- ^ Gould, SJ, The Median Isn't the Message, retrieved 1 November 2014
- ^ "Multiple Myeloma Prognosis". Multiple Myeloma Prognosis.
- ^ Kim, Peter; Daly, Jeanette M.; Berry-Stoelzle, Maresi A.; Schmidt, Megan E.; Michaels, LeAnn C.; Dorr, David A.; Levy, Barcey T. (March 2020). "Prognostic Indices for Advance Care Planning in Primary Care: A Scoping Review". The Journal of the American Board of Family Medicine. 33 (2): 322–338. doi:10.3122/jabfm.2020.02.190173. ISSN 1557-2625. PMC 7772823. PMID 32179616.
- ^ "The Internet Classics Archive - The Book of Prognostics by Hippocrates". classics.mit.edu. Retrieved 19 March 2018.